|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$94,042.53 |
3.04% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$83,680.25 |
2.70% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$82,382.56 |
2.66% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$80,383.58 |
2.59% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$76,129.86 |
2.46% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$75,568.14 |
2.44% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$75,323.52 |
2.43% |
| Waters Corporation |
WAT |
941848103 |
184 |
$73,600.00 |
2.38% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$73,398.46 |
2.37% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,456.31 |
2.37% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$73,538.56 |
2.37% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$72,389.43 |
2.34% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$71,799.33 |
2.32% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$70,473.96 |
2.28% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$69,198.14 |
2.23% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$68,116.44 |
2.20% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$68,183.94 |
2.20% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,822.13 |
2.19% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$67,350.29 |
2.17% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$66,206.16 |
2.14% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$65,192.12 |
2.10% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$64,697.94 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$63,968.40 |
2.07% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$62,157.48 |
2.01% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,135.28 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$61,894.60 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$61,967.52 |
2.00% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,668.15 |
1.99% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,376.90 |
1.95% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$59,442.20 |
1.92% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$59,225.58 |
1.91% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$58,643.22 |
1.89% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,135.12 |
1.88% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$58,129.24 |
1.88% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,799.74 |
1.87% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,531.38 |
1.86% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$56,683.68 |
1.83% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$55,028.40 |
1.78% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$53,137.74 |
1.72% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$52,512.08 |
1.70% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,481.51 |
1.69% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$48,776.00 |
1.57% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,277.71 |
1.56% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$47,245.63 |
1.53% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,344.78 |
1.50% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$45,591.70 |
1.47% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,664.38 |
1.34% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$40,606.00 |
1.31% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$39,978.00 |
1.29% |
| US Dollar |
$USD |
|
13,396 |
$13,396.12 |
0.43% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|